Loading…
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011
Legislative Progress
Introduced
September 20, 2011
Latest Action
September 26, 2011
Primary Sponsor
Michael C. BurgessRepublican(TX)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
37pct
6d open
vs 6,662 other HR bills in the 112th — cohort avg 39d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (8)
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2013 · fourth_quarter · Health Issues
Research in Kidney Disease FDA drug development H.R. 2969: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011
Client expense: Not reported · Firm income: $10,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2013 · third_quarter · Health Issues
Research in Kidney Disease FDA drug development H.R. 2969: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011
Client expense: Not reported · Firm income: $10,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2013 · second_quarter · Health Issues
Research in Kidney Disease FDA drug development H.R. 2969: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011
Client expense: Not reported · Firm income: $10,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2013 · first_quarter · Health Issues
Research in Kidney Disease FDA drug development H.R. 2969: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011
Client expense: Not reported · Firm income: $10,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2012 · fourth_quarter · Health Issues
H.R. 1862, Regenerative Medicine Promotion Act of 2011 H.R. 2787/S. 1468, Medicare Diabetes Self-Management Training Act H.R. 2969/S. 1454 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011 H.R. 2960/S. 3430 National Diabetes Clinical Care Commission ActH.R. 6309, To amend the Public Health Service Act to reauthorize the special diabetes programs for Type I diabetes and Indians under that Act. H.R. 3150/S. 725 Medicare Safe Needle Disposal Coverage Act of 2011
Client expense: $430,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · third_quarter · Medicare/Medicaid
S. 668, Health Care Bureaucrats Elimination Act - Lobbied for passage of bill to eliminate the Independent Payment Advisory Board. H.R. 452, Medicare Decisions Accountability Act - Lobbied for passage of bill to eliminate the Independent Payment Advisory Board.Bill not yet introduced, The Medicare Home Infusion Therapy Coverage Act - Lobbied for expanded coverage of home infusion therapy. S. 1454 and H.R. 2969, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for extended coverage of immunosuppresive drugs in Medicare. H.R. 2190 and S. 1206, Medicare Drug Savings Act of 2011 - Lobbied to oppose extending Medicaid rebates to Medicare Part D. No Bill, Health care reform implementation. Lobbied CMS on new definition of the Average Manufacturer's Price calculation in Medicaid.
Client expense: $560,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, Treasury, Dept of
2012 · fourth_quarter · Medicare/Medicaid
Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152). Issues related to Medicare covering immunosuppressants for ESRD patients post transplant (H.R. 2969).
Client expense: $400,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · fourth_quarter · Medicare/Medicaid
S. 668, Health Care Bureaucrats Elimination Act - Lobbied for passage of bill to eliminate the Independent Payment Advisory Board. H.R. 452, Medicare Decisions Accountability Act - Lobbied for passage of bill to eliminate the Independent Payment Advisory Board. Bill not yet introduced, The Medicare Home Infusion Therapy Coverage Act - Lobbied for expanded coverage of home infusion therapy. S. 1454 and H.R. 2969, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for extended coverage of immunosuppresive drugs in Medicare. H.R. 2190 and S. 1206, Medicare Drug Savings Act of 2011 - Lobbied to oppose extending Medicaid rebates to Medicare Part D. No Bill, Health care reform implementation. Lobbied CMS on new definition of the Average Manufacturer's Price calculation in Medicaid.
Client expense: $1,280,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, Treasury, Dept of
2012 · fourth_quarter · Health Issues
H.R. 1862, Regenerative Medicine Promotion Act of 2011 H.R. 2787/S. 1468, Medicare Diabetes Self-Management Training Act H.R. 2969/S. 1454 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011 H.R. 2960/S. 3430 National Diabetes Clinical Care Commission Act H.R. 6309, To amend the Public Health Service Act to reauthorize the special diabetes programs for Type I diabetes and Indians under that Act. H.R. 3150/S. 725 Medicare Safe Needle Disposal Coverage Act of 2011
Client expense: $420,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · fourth_quarter · Health Issues
HR 2969/ S 1454 -- Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011 Living Donor Registry Clinical Laboratory Assay Blood Safety Issues
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · fourth_quarter · Budget/Appropriations
FY13 L-HHS Appropriations Bill H.R. 2969 & S. 1454: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients of 2011 FY13 DoD Bill
Client expense: Not reported · Firm income: $5,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · fourth_quarter · Health Issues
P.L.111-148/P.L.111-152, Affordable Care Act, Health care reform in general. H.R. 2969/S. 1454, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011. No Bill #, Legislation regarding Medicare physician payment, chronic kidney disease, end-stage renal disease Medicare payment and quality. No Bill # - Best Pharmaceuticals for Children Act reauthorization.
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2012 · fourth_quarter · Health Issues
Research in Kidney Disease FDA drug development H.R. 2969: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011
Client expense: Not reported · Firm income: $10,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2012 · fourth_quarter · Medicare/Medicaid
S. 1454 / H.R. 2969 - Extend Medicare coverage of immunosuppressive medications for kidney transplant patients S. 3271 - Extend guaranteed issue of Medigap policies for kidney disease patients Potential incentives for innovation in ESRD bundled payment system Transition of oral-only medications into ESRD bundle
Client expense: $10,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), SENATE, Treasury, Dept of, White House Office
2012 · third_quarter · Medicare/Medicaid
Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152). Issues related to Medicare covering immunosuppressants for ESRD patients post transplant (H.R. 2969).
Client expense: $560,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · third_quarter · Health Issues
HR 2969/ S 1454 -- Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011 Living Donor Registry Clinical Laboratory Assay Blood Safety Issues
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · third_quarter · Health Issues
H.R. 1862, Regenerative Medicine Promotion Act of 2011 H.R. 2787/S. 1468, Medicare Diabetes Self-Management Training Act S. 2236, Advancing Breakthrough Therapies for Patients Act H.R. 2969/S. 1454 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011 H.R. 5651, Food and Drug Administration Reform Act of 2012 S. 3187 Food and Drug Administration Safety & Innovation Act H.R. 6309, To amend the Public Health Service Act to reauthorize the special diabetes programs for Type I diabetes and Indians under that Act. H.R. 2960/S. 3430 National Diabetes Clinical Care Commission Act H.R. 3150/S. 725 Medicare Safe Needle Disposal Coverage Act of 2011
Client expense: $370,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · third_quarter · Medicare/Medicaid
S.1454 / H.R. 2969 - Extend Medicare coverage of immunosuppressive medications for kidney transplant patients S. 3271 - Extend guaranteed issue of Medigap policies for kidney disease patients Potential incentives for innovation inn ESRD bundled payment system Transition of oral-only medications into ESRD bundle
Client expense: $20,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), SENATE, Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
2012 · third_quarter · Budget/Appropriations
FY13 L-HHS Appropriations Bill H.R. 2969 & S. 1454: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients of 2011 FY13 DoD Bill
Client expense: Not reported · Firm income: $5,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · third_quarter · Health Issues
P.L.111-148/P.L.111-152, Affordable Care Act, Health care reform in general. H.R. 2969/S. 1454, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011. No Bill #, Legislation regarding Medicare physician payment, chronic kidney disease, end-stage renal disease Medicare payment and quality. No Bill # - Best Pharmaceuticals for Children Act reauthorization.
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2012 · third_quarter · Medicare/Medicaid
S. 668, Health Care Bureaucrats Elimination Act - Lobbied for passage of bill to eliminate the Independent Payment Advisory Board. H.R. 452, Medicare Decisions Accountability Act - Lobbied for passage of bill to eliminate the Independent Payment Advisory Board. Bill not yet introduced, The Medicare Home Infusion Therapy Coverage Act - Lobbied for expanded coverage of home infusion therapy. S. 1454 and H.R. 2969, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for extended coverage of immunosuppresive drugs in Medicare. H.R. 2190 and S. 1206, Medicare Drug Savings Act of 2011 - Lobbied to oppose extending Medicaid rebates to Medicare Part D. No Bill, Health care reform implementation. Lobbied CMS on new definition of the Average Manufacturer's Price calculation in Medicaid.
Client expense: $520,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, Treasury, Dept of
2012 · second_quarter · Medicare/Medicaid
Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152). Issues related to Medicare covering immunosuppressants for ESRD patients post transplant (H.R. 2969).
Client expense: $580,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · second_quarter · Health Issues
Living Donor Registry Clinical Laboratory Assay Blood Safety Issues HR 2969/ S 1454 -- Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · second_quarter · Health Issues
H.R. 1862, Regenerative Medicine Promotion Act of 2011 H.R. 2787/S. 1468, Medicare Diabetes Self-Management Training Act H.R. 2960, National Diabetes Clinical Care Commission Act S. 2236, Advancing Breakthrough Therapies for Patients Act H.R. 2969/S. 1454 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011 H.R. 5651, Food and Drug Administration Reform Act of 2012 S. 3187 Food and Drug Administration Safety & Innovation Act S. 725, Medicare Safe Needle Disposal Coverage Act of 2011
Client expense: $30,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · second_quarter · Health Issues
H.R. 1862, Regenerative Medicine Promotion Act of 2011 H.R. 2787/S. 1468, Medicare Diabetes Self-Management Training Act H.R. 2960, National Diabetes Clinical Care Commission Act S. 2236, Advancing Breakthrough Therapies for Patients Act H.R. 2969/S. 1454 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011 H.R. 5651, Food and Drug Administration Reform Act of 2012 S. 3187 Food and Drug Administration Safety & Innovation Act S. 725, Medicare Safe Needle Disposal Coverage Act of 2011
Client expense: $30,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · first_quarter · Medicare/Medicaid
S. 668, Health Care Bureaucrats Elimination Act - Lobbied for passage of bill to eliminate the Independent Payment Advisory Board. H.R. 452, Medicare Decisions Accountability Act - Lobbied for passage of bill to eliminate the Independent Payment Advisory Board. Bill not yet introduced, The Medicare Home Infusion Therapy Coverage Act - Lobbied for expanded coverage of home infusion therapy. S. 1454 and H.R. 2969, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for extended coverage of immunosuppresive drugs in Medicare. H.R. 2190 and S. 1206, Medicare Drug Savings Act of 2011 - Lobbied to oppose extending Medicaid rebates to Medicare Part D.
Client expense: $820,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, Treasury, Dept of
2012 · second_quarter · Medicare/Medicaid
S. 668, Health Care Bureaucrats Elimination Act - Lobbied for passage of bill to eliminate the Independent Payment Advisory Board. H.R. 452, Medicare Decisions Accountability Act - Lobbied for passage of bill to eliminate the Independent Payment Advisory Board. Bill not yet introduced, The Medicare Home Infusion Therapy Coverage Act - Lobbied for expanded coverage of home infusion therapy. S. 1454 and H.R. 2969, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for extended coverage of immunosuppresive drugs in Medicare. H.R. 2190 and S. 1206, Medicare Drug Savings Act of 2011 - Lobbied to oppose extending Medicaid rebates to Medicare Part D.
Client expense: $660,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, Treasury, Dept of
2012 · first_quarter · Medicare/Medicaid
S. 668, Health Care Bureaucrats Elimination Act - Lobbied for passage of bill to eliminate the Independent Payment Advisory Board. H.R. 452, Medicare Decisions Accountability Act - Lobbied for passage of bill to eliminate the Independent Payment Advisory Board. Bill not yet introduced, The Medicare Home Infusion Therapy Coverage Act - Lobbied for expanded coverage of home infusion therapy. S. 1454 and H.R. 2969, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for extended coverage of immunosuppresive drugs in Medicare. H.R. 2190 and S. 1206, Medicare Drug Savings Act of 2011 - Lobbied to oppose extending Medicaid rebates to Medicare Part D.
Client expense: $820,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, Treasury, Dept of
2012 · second_quarter · Budget/Appropriations
FY13 Labor-HHS Appropriations Bill H.R. 2969 & S. 1454: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients of 2011 FY 13 DoD Bill
Client expense: Not reported · Firm income: $5,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · second_quarter · Health Issues
P.L.111-148/P.L.111-152, Affordable Care Act, Health care reform in general. H.R. 2969/S. 1454, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011. No Bill #, Legislation regarding Medicare physician payment, chronic kidney disease, end-stage renal disease Medicare payment and quality. No Bill # - Best Pharmaceuticals for Children Act reauthorization.
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2012 · second_quarter · Medicare/Medicaid
S. 1454 / H.R. 2969 - Comprehensive immunosuppressive drug coverage for kidney transplant patients Potential incentives for innovation in ESRD bundled payment system Transition of oral-only medications into ESRD bundle S. 3271 - Equal access to Medicare options for kidney disease patient, by extending guaranteed issuance of Medigap policies
Client expense: $25,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
2012 · first_quarter · Medicare/Medicaid
S. 668, Health Care Bureaucrats Elimination Act - Lobbied for passage of bill to eliminate the Independent Payment Advisory Board. H.R. 452, Medicare Decisions Accountability Act - Lobbied for passage of bill to eliminate the Independent Payment Advisory Board. Bill not yet introduced, The Medicare Home Infusion Therapy Coverage Act - Lobbied for expanded coverage of home infusion therapy. S. 1454 and H.R. 2969, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for extended coverage of immunosuppresive drugs in Medicare. H.R. 2190 and S. 1206, Medicare Drug Savings Act of 2011 - Lobbied to oppose extending Medicaid rebates to Medicare Part D.
Client expense: $860,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, Treasury, Dept of
2012 · first_quarter · Health Issues
H.R. 1862, Regenerative Medicine Promotion Act of 2011 H.R. 2787/S. 1468, Medicare Diabetes Self-Management Training Act H.R. 2960, National Diabetes Clinical Care Commission Act S. 2236, Advancing Breakthrough Therapies for Patients Act H.R. 2969/S. 1454 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · first_quarter · Health Issues
Living Donor Registry Clinical Laboratory Assay Blood Safety Issues HR 2969/ S 1454 -- Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · first_quarter · Medicare/Medicaid
S 1454 / H.R. 2969 - Comprehensive Immunosuppressive Drug Coverage for Kidney Transplnt Patients Potential incentives for innovatiob in ESRD bundled payment system Transition of oral-only medications into ESRD bundle
Client expense: $75,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA), White House Office
2012 · first_quarter · Health Issues
P.L.111-148/P.L.111-152, Affordable Care Act, Health care reform in general. H.R. 2969/S. 1454, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011. No Bill #, Legislation regarding Medicare physician payment, chronic kidney disease, end-stage renal disease Medicare payment and quality. No Bill # - Best Pharmaceuticals for Children Act reauthorization.
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2012 · first_quarter · Budget/Appropriations
FY13 Labor-HHS Appropriations Bill H.R. 2969 & S. 1454: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients of 2011
Client expense: Not reported · Firm income: $5,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · fourth_quarter · Health Issues
Living Donor Registry; Clinical Laboratory Assay; Blood Safety Issues; HR 2969/ S 1454 -- Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2011 · fourth_quarter · Health Issues
H.R. 1862, Regenerative Medicine Promotion Act of 2011 H.R. 2787/S. 1468, Medicare Diabetes Self-Management Training Act H.R. 2376, Stem Cell Research Advancement Act of 2011 H.R. 2960, National Diabetes Clinical Care Commission Act H.R. 2969/S. 1454, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011
Client expense: $40,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · fourth_quarter · Medicare/Medicaid
S. 1454 / H.R. 2969 - Comprehensive Immunosuppresive Drug Coverage for Kidney Transplant Patients Potential incentives for innovation in ESRD bundled payment system
Client expense: $60,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2011 · fourth_quarter · Medicare/Medicaid
S. 668, Health Care Bureaucrats Elimination Act - Lobbied for passage of bill to eliminate the Independent Payment Advisory Board. H.R. 452, Medicare Decisions Accountability Act - Lobbied for passage of bill to eliminate the Independent Payment Advisory Board. Bill not yet introduced, The Medicare Home Infusion Therapy Coverage Act - Lobbied for expanded coverage of home infusion therapy. S. 1454 and H.R. 2969, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for extended coverage of immunosuppresive drugs in Medicare. H.R. 2190 and S. 1206, Medicare Drug Savings Act of 2011 - Lobbied to oppose extending Medicaid rebates to Medicare Part D.
Client expense: $870,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, Treasury, Dept of
2011 · fourth_quarter · Health Issues
P.L.111-148/P.L.111-152, Affordable Care Act, Health care reform in general. H.R. 2969/S. 1454, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011. No Bill #, Legislation regarding Medicare physician payment, chronic kidney disease, end-stage renal disease Medicare payment and quality.
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2011 · fourth_quarter · Budget/Appropriations
FY12 Labor-HHS Appropriations Bill H.R. 2969 & S. 1454: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients of 2011
Client expense: Not reported · Firm income: $5,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · third_quarter · Health Issues
H.R. 2376 Stem Cell Research Advancement Act of 2011 H.R. 1862 Regenerative Medicine Promotion Act of 2011 H.R. 2969/S.1454 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011
Client expense: $40,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · third_quarter · Health Issues
S. 1454 / H.R. 2969 - Comprehensive Immunosuppressive Drug Coverage for Kidney Transplants Patients Act Extension of Medicare Secondary Payer Law to Health exchanges Application of health exchange subsidies for ESRD patients Coverage of dialysis and transplantation in Essential Health Benefits Package Ensuring adequacy of networks and consumer protections in Health Insurance Exchanges Application of Association Health Plan protections in Health Insurance Exchanges Patient Protections in ESRD Quality Incentive Program Patient involvement in infection prevention efforts at dialysis facilities Potential incentives for innovation in ESRD bundled payment system Support for the Congressional Kidney Caucus
Client expense: $60,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Treasury, Dept of, White House Office
2011 · second_quarter · Health Issues
S. 1454 / H.R. 2969 - Comprehensive Immunosuppressive Drug Coverage for Kidney Transplants Patients Act Extension of Medicare Secondary Payer Law to Health exchanges Application of health exchange subsidies for ESRD patients Coverage of dialysis and transplantation in Essential Health Benefits Package Ensuring adequacy of networks and consumer protections in Health Insurance Exchanges Application of Association Health Plan protections in Health Insurance Exchanges Patient Protections in ESRD Quality Incentive Program Patient involvement in infection prevention efforts at dialysis facilities Potential incentives for innovation in ESRD bundled payment system Support for the Congressional Kidney Caucus
Client expense: $60,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Treasury, Dept of, White House Office
2011 · third_quarter · Health Issues
Living Donor Registry Clinical Laboratory Assay Transplant Biovigilance Issues HR 2969/ S 1454 -- Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2011 · third_quarter · Medicare/Medicaid
S. 668, Health Care Bureaucrats Elimination Act - Lobbied for passage of bill to eliminate the Independent Payment Advisory Board. H.R. 452, Medicare Decisions Accountability Act - Lobbied for passage of bill to eliminate the Independent Payment Advisory Board. Bill not yet introduced, The Medicare Home Infusion Therapy Coverage Act - Lobbied for expanded coverage of home infusion therapy. S. 1454 and H.R. 2969, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for extended coverage of immunosuppresive drugs in Medicare. H.R. 2190 and S. 1206, Medicare Drug Savings Act of 2011 - Lobbied to oppose extending Medicaid rebates to Medicare Part D.
Client expense: $660,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, Treasury, Dept of
2011 · third_quarter · Health Issues
P.L. 111-148/P.L.111-152, Affordable Care Act, Health care reform in general. H.R. 2969/S. 1454, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011. No Bill #, Legislation regarding Medicare physician payment, chronic kidney disease, end-stage renal disease Medicare payment
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2011 · third_quarter · Budget/Appropriations
FY12 Labor-HHS Appropriations Bill HR 2969 & S 1454: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients of 2011
Client expense: Not reported · Firm income: $5,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Democratic |
| FL |
| Allen B. West | Republican | FL |
| Ander Crenshaw | Republican | FL |
| André Carson | Democratic | IN |
| Barbara Lee | Democratic | CA |
| Barney Frank | Democratic | MA |
| Ben Ray Luján | Democratic | NM |
| Bennie G. Thompson | Democratic | MS |
| Betty McCollum | Democratic | MN |
| Bill Cassidy | Republican | LA |
| Bill Johnson | Republican | OH |
| Bill Posey | Republican | FL |
| Blaine Luetkemeyer | Republican | MO |
| Bob Filner | Democratic | CA |
| Brad Miller | Democratic | NC |
| C. W. Bill Young | Republican | FL |
| Candice S. Miller | Republican | MI |
| Carolyn McCarthy | Democratic | NY |
| Charles B. Rangel | Democratic | NY |
| Chellie Pingree | Democratic | ME |
| Chris Van Hollen | Democratic | MD |
| Christopher H. Smith | Republican | NJ |
| Collin C. Peterson | Democratic | MN |
| Corrine Brown | Democratic | FL |
| Dale E. Kildee | Democratic | MI |
| Dan Benishek | Republican | MI |
| Dan Boren | Democratic | OK |
| Daniel Lipinski | Democratic | IL |
| David B. McKinley | Republican | WV |
| David E. Price | Democratic | NC |
| David Loebsack | Democratic | IA |
| David N. Cicilline | Democratic | RI |
| David Rivera | Republican | FL |
| Diana DeGette | Democratic | CO |
| Donald Payne | Democratic | NJ |
| Earl Blumenauer | Democratic | OR |
| Edolphus Towns | Democratic | NY |
| Edward J. Markey | Democratic | MA |
| Eleanor Holmes Norton | Democratic | DC |
| Elijah E. Cummings | Democratic | MD |
| Erik Paulsen | Republican | MN |
| Fortney Pete Stark | Democratic | CA |
| Frank R. Wolf | Republican | VA |
| Gary C. Peters | Democratic | MI |
| Gary L. Ackerman | Democratic | NY |
| Gene Green | Democratic | TX |
| Gerald E. Connolly | Democratic | VA |
| Hansen Clarke | Democratic | MI |
| Henry C. "Hank" Johnson, Jr. | Democratic | GA |
| J. Randy Forbes | Republican | VA |
| James A. Himes | Democratic | CT |
| James B. Renacci | Republican | OH |
| James P. McGovern | Democratic | MA |
| James P. Moran | Democratic | VA |
| James R. Langevin | Democratic | RI |
| Janice D. Schakowsky | Democratic | IL |
| Janice Hahn | Democratic | CA |
| Jay Inslee | Democratic | WA |
| Jerrold Nadler | Democratic | NY |
| Jerry Lewis | Republican | CA |
| Jesse L. Jackson Jr. | Democratic | IL |
| Jim Cooper | Democratic | TN |
| Jim Costa | Democratic | CA |
| Jim Gerlach | Republican | PA |
| Jim McDermott | Democratic | WA |
| Jo Ann Emerson | Republican | MO |
| Joe Baca | Democratic | CA |
| John Conyers, Jr. | Democratic | MI |
| John F. Tierney | Democratic | MA |
| John Lewis | Democratic | GA |
| Judy Chu | Democratic | CA |
| Kathy Castor | Democratic | FL |
| Keith Ellison | Democratic | MN |
| Kenny Marchant | Republican | TX |
| Larry Kissell | Democratic | NC |
| Laura Richardson | Democratic | CA |
| Leonard Lance | Republican | NJ |
| Linda T. Sánchez | Democratic | CA |
| Lois Capps | Democratic | CA |
| Lucille Roybal-Allard | Democratic | CA |
| Lynn C. Woolsey | Democratic | CA |
| Mario Diaz-Balart | Republican | FL |
| Marsha Blackburn | Republican | TN |
| Martin Heinrich | Democratic | NM |
| Mary Bono Mack | Republican | CA |
| Maurice D. Hinchey | Democratic | NY |
| Michael G. Fitzpatrick | Republican | PA |
| Michael G. Grimm | Republican | NY |
| Michael H. Michaud | Democratic | ME |
| Michele Bachmann | Republican | MN |
| Mike Rogers | Republican | MI |
| Mike Ross | Democratic | AR |
| Nick J. Rahall II | Democratic | WV |
| Niki Tsongas | Democratic | MA |
| Patrick Meehan | Republican | PA |
| Paul A. Gosar | Republican | AZ |
| Paul Tonko | Democratic | NY |
| Pedro R. Pierluisi | Democratic | PR |
| Raúl M. Grijalva | Democratic | AZ |
| Robert Hurt | Republican | VA |
| Robert J. Wittman | Republican | VA |
| Robert L. Turner | Republican | NY |
| Ron Kind | Democratic | WI |
| Roscoe G. Bartlett | Republican | MD |
| Rush Holt | Democratic | NJ |
| Russ Carnahan | Democratic | MO |
| Sam Farr | Democratic | CA |
| Sanford D. Bishop, Jr. | Democratic | GA |
| Sheila Jackson Lee | Democratic | TX |
| Shelley Moore Capito | Republican | WV |
| Silvestre Reyes | Democratic | TX |
| Spencer Bachus | Republican | AL |
| Steve Cohen | Democratic | TN |
| Steven R. Rothman | Democratic | NJ |
| Susan A. Davis | Democratic | CA |
| Thaddeus McCotter | Republican | MI |
| Theodore E. Deutch | Democratic | FL |
| Tim Holden | Democratic | PA |
| Tim Scott | Republican | SC |
| Todd Russell Platts | Republican | PA |
| Tom Latham | Republican | IA |
| Tom Marino | Republican | PA |
| Walter B. Jones | Republican | NC |
| Zoe Lofgren | Democratic | CA |